<VariationArchive RecordType="classified" VariationID="4857" VariationName="NM_023067.4(FOXL2):c.178_192dup (p.Val60_Ala64dup)" VariationType="Duplication" Accession="VCV000004857" Version="2" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2022-12-31" DateCreated="2013-04-04" MostRecentSubmission="2019-06-23">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="19896" VariationID="4857">
      <GeneList>
        <Gene Symbol="FOXL2" FullName="forkhead box L2" GeneID="668" HGNC_ID="HGNC:1092" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>3q22.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="138944224" stop="138947137" display_start="138944224" display_stop="138947137" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="138663065" stop="138665981" display_start="138663065" display_stop="138665981" Strand="-" />
          </Location>
          <OMIM>605597</OMIM>
          <Haploinsufficiency last_evaluated="2021-02-09" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FOXL2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-02-09" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FOXL2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_023067.4(FOXL2):c.178_192dup (p.Val60_Ala64dup)</Name>
      <CanonicalSPDI>NC_000003.12:138946530:GGCGATGAGCGCCACG:GGCGATGAGCGCCACGGCGATGAGCGCCACG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>3q22.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="138946530" stop="138946531" display_start="138946530" display_stop="138946531" variantLength="15" positionVCF="138946530" referenceAlleleVCF="T" alternateAlleleVCF="TGGCGATGAGCGCCAC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="138665372" stop="138665373" display_start="138665372" display_stop="138665373" variantLength="15" positionVCF="138665372" referenceAlleleVCF="T" alternateAlleleVCF="TGGCGATGAGCGCCAC" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.138665374_138665388dup" Assembly="GRCh37">
            <Expression>NC_000003.11:g.138665374_138665388dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.138946532_138946546dup" Assembly="GRCh38">
            <Expression>NC_000003.12:g.138946532_138946546dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012454.1" sequenceAccession="NG_012454" sequenceVersion="1" change="g.5596_5610dup">
            <Expression>NG_012454.1:g.5596_5610dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_029796.1" sequenceAccession="NG_029796" sequenceVersion="1" change="g.4299_4313dup">
            <Expression>NG_029796.1:g.4299_4313dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_023067.4" sequenceAccession="NM_023067" sequenceVersion="4" change="c.178_192dup" MANESelect="true">
            <Expression>NM_023067.4:c.178_192dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_075555.1" sequenceAccession="NP_075555" sequenceVersion="1" change="p.Val60_Ala64dup">
            <Expression>NP_075555.1:p.Val60_Ala64dup</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001821" Type="inframe_insertion" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1295" sequenceAccession="LRG_1295">
            <Expression>LRG_1295:g.5596_5610dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1295t1" sequenceAccession="LRG_1295t1">
            <Expression>LRG_1295t1:c.178_192dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1295p1" sequenceAccession="LRG_1295p1" change="p.Val60_Ala64dup">
            <Expression>LRG_1295p1:p.Val60_Ala64dup</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA213132" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="605597.0005" DB="OMIM" />
        <XRef Type="rs" ID="863225452" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff reviewed the sequence information reported in PubMed 1468277 Fig. 2K to determine the location of this allele on the current reference sequence.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_023067.4(FOXL2):c.178_192dup (p.Val60_Ala64dup) AND BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE II" Accession="RCV000005131" Version="2">
        <ClassifiedConditionList TraitSetID="19739">
          <ClassifiedCondition DB="MedGen" ID="C2931136">BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE II</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2001-07-15" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_023067.4(FOXL2):c.178_192dup (p.Val60_Ala64dup) AND Blepharophimosis, ptosis, and epicanthus inversus syndrome" Accession="RCV000785831" Version="1">
        <ClassifiedConditionList TraitSetID="1337">
          <ClassifiedCondition DB="MedGen" ID="C0220663">Blepharophimosis, ptosis, and epicanthus inversus syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2011-01-01" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2011-01-01" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2013-04-04" MostRecentSubmission="2019-06-23">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11468277</ID>
        </Citation>
        <DescriptionHistory Dated="2019-06-22">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="19739" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="7586" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE II</ElementValue>
                <XRef Type="Allelic variant" ID="605597.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="605597.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="605597.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="605597.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="605597.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="605597.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="605597.0020" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">BPES without ovarian failure</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Blepharophimosis, ptosis, and epicanthus inversus syndrome type 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Blepharophimosis syndrome type 2</ElementValue>
                <XRef ID="Blepharophimosis+Syndrome+Type+2/871" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">BPES type 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Blepharophimosis, ptosis, and epicanthus inversus type 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Blepharophimosis, ptosis, and epicanthus inversus without premature ovarian failure</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">BPES without premature ovarian failure</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">BPES II</ElementValue>
              </Symbol>
              <XRef ID="C2931136" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1337" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4679" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Blepharophimosis, ptosis, and epicanthus inversus</ElementValue>
                <XRef ID="Blepharophimosis%2C+ptosis%2C+and+epicanthus+inversus/7828" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Blepharophimosis, ptosis, and epicanthus inversus syndrome</ElementValue>
                <XRef ID="3351" DB="GeneTests" />
                <XRef ID="MONDO:0007201" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">BPES</ElementValue>
                <XRef Type="MIM" ID="110100" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Blepharophimosis, ptosis, and epicanthus inversus syndrome (BPES) is defined by a complex eyelid malformation characterized by four major features, all present at birth: blepharophimosis, ptosis, epicanthus inversus, and telecanthus. BPES type I includes the four major features and primary ovarian insufficiency; BPES type II includes only the four major features. Other ophthalmic manifestations that can be associated with BPES include dysplastic eyelids, lacrimal duct anomalies, strabismus, refractive errors, and amblyopia. Other craniofacial features may include a broad nasal bridge and low-set ears.</Attribute>
                <XRef ID="NBK1441" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="23" />
                <XRef ID="23" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301614</ID>
                <ID Source="BookShelf">NBK1441</ID>
              </Citation>
              <XRef ID="126" DB="Orphanet" />
              <XRef ID="C0220663" DB="MedGen" />
              <XRef ID="MONDO:0007201" DB="MONDO" />
              <XRef Type="MIM" ID="110100" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="25308" SubmissionDate="2012-04-17" DateLastUpdated="2013-04-04" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="605597.0005_BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE II" title="FOXL2, 15-BP DUP, NT415_BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE II" />
        <ClinVarAccession Accession="SCV000025308" DateUpdated="2013-04-04" DateCreated="2013-04-04" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2001-07-15">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a family with BPES type II (110100), De Baere et al. (2001) found that affected members had a 15-bp duplication at position 415 to 429, resulting in duplication of amino acids 60 to 64 within the forkhead domain.</Attribute>
              <Citation>
                <ID Source="PubMed">11468277</ID>
              </Citation>
              <XRef DB="OMIM" ID="110100" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FOXL2" />
          </GeneList>
          <Name>FOXL2, 15-BP DUP, NT415</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">15-BP DUP, NT415</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="605597.0005" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE II</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1807740" SubmissionDate="2019-03-08" DateLastUpdated="2019-06-23" DateCreated="2019-06-23">
        <ClinVarSubmissionID localKey="1104227|OMIM:110100" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000924404" DateUpdated="2019-06-23" DateCreated="2019-06-23" Type="SCV" Version="1" SubmitterName="Wessex Regional Genetics Laboratory, Salisbury District Hospital" OrgID="506925" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2011-01-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <TypePlatform>Sanger sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FOXL2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>p.(Val60_Ala64dup)</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_023067.3:c.178_192dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="110100" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5295063</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="25308" TraitType="Disease" MappingType="Name" MappingValue="BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE II" MappingRef="Preferred">
        <MedGen CUI="C2931136" Name="BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE II" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1807740" TraitType="Disease" MappingType="XRef" MappingValue="110100" MappingRef="OMIM">
        <MedGen CUI="C0220663" Name="Blepharophimosis, ptosis, and epicanthus inversus syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

